company background image
PCR logo

PCC Rokita WSE:PCR Stock Report

Last Price

zł104.00

Market Cap

zł2.1b

7D

-0.6%

1Y

-25.3%

Updated

27 Mar, 2024

Data

Company Financials +

PCC Rokita SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PCC Rokita
Historical stock prices
Current Share Pricezł104.00
52 Week Highzł152.20
52 Week Lowzł81.10
Beta1.17
1 Month Change9.47%
3 Month Change11.83%
1 Year Change-25.29%
3 Year Change50.72%
5 Year Change17.12%
Change since IPO213.63%

Recent News & Updates

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Aug 24
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Recent updates

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Aug 24
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 29
PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Is PCC Rokita (WSE:PCR) A Risky Investment?

Jan 18
Is PCC Rokita (WSE:PCR) A Risky Investment?

PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Apr 16
PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Why We Like The Returns At PCC Rokita (WSE:PCR)

Mar 19
Why We Like The Returns At PCC Rokita (WSE:PCR)

What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

Jan 25
What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Sep 01
We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Jun 14
Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

May 18
Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Apr 13
Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

Mar 23
Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Mar 09
PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

Feb 19
Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Feb 04
What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Jan 15
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Dec 30
Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

Dec 17
Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 03
PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Nov 20
Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Shareholder Returns

PCRPL ChemicalsPL Market
7D-0.6%-1.1%2.3%
1Y-25.3%-18.4%35.3%

Return vs Industry: PCR underperformed the Polish Chemicals industry which returned -17.5% over the past year.

Return vs Market: PCR underperformed the Polish Market which returned 35.7% over the past year.

Price Volatility

Is PCR's price volatile compared to industry and market?
PCR volatility
PCR Average Weekly Movement3.1%
Chemicals Industry Average Movement3.9%
Market Average Movement5.0%
10% most volatile stocks in PL Market9.5%
10% least volatile stocks in PL Market3.2%

Stable Share Price: PCR has not had significant price volatility in the past 3 months.

Volatility Over Time: PCR's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19931,446Wieslaw Klimkowskihttps://www.pcc.rokita.pl

PCC Rokita SA manufactures and distributes chemical products in Poland and internationally. The company offers chlorine and alkali; polyurethanes; household chemicals and cleaning agents; washing preparations; liquid chemicals and disinfectants; vegan body and hair care products; shower gels, hair shampoos, and liquid soaps; flexible foams; and organic products, as well as polyols, naphthalene, and phosphorus derivatives. The company also provides specialty products, including anionic surfactants, alkoxylated fatty alcohols, non-ionic surfactants, synthetic and foam-forming extinguishing agents, synthetic base oils and additives, polyester polyols, chemical raw materials, polyurethane adhesives, prepolymers, polymeric polyols, and polyether polyols.

PCC Rokita SA Fundamentals Summary

How do PCC Rokita's earnings and revenue compare to its market cap?
PCR fundamental statistics
Market capzł2.06b
Earnings (TTM)zł267.84m
Revenue (TTM)zł2.39b

7.7x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PCR income statement (TTM)
Revenuezł2.39b
Cost of Revenuezł1.80b
Gross Profitzł584.25m
Other Expenseszł316.41m
Earningszł267.84m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 15, 2024

Earnings per share (EPS)13.49
Gross Margin24.46%
Net Profit Margin11.22%
Debt/Equity Ratio37.9%

How did PCR perform over the long term?

See historical performance and comparison

Dividends

20.7%

Current Dividend Yield

91%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.